Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03578367
Title Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

chronic myeloid leukemia

Therapies

Imatinib

Nilotinib

Asciminib + Imatinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | AUT

Facility Status City State Zip Country Details
Georgia Regents University Recruiting Augusta Georgia 30912 United States Details
University of Chicago Recruiting Chicago Illinois 60637 United States Details
Sidney Kimmel Comprehensive Cancer Center Completed Baltimore Maryland 21205 United States Details
Saint Agnes Healthcare Cancer Institute Withdrawn Baltimore Maryland 21229 United States Details
SUNY Stony Brook Medical Oncology Hematology/Oncology Withdrawn Stony Brook New York 11794-8174 United States Details
University of Texas MD Anderson Cancer Center Withdrawn Houston Texas 77030 United States Details
Novartis Investigative Site Withdrawn Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site Withdrawn Adelaide South Australia 5000 Australia Details
Novartis Investigative Site Withdrawn Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Withdrawn Graz 8036 Austria Details
Novartis Investigative Site Recruiting Wien 1140 Austria Details
Novartis Investigative Site Recruiting Montreal Quebec H1T 2M4 Canada Details
Novartis Investigative Site Withdrawn Temuco Araucania 4800827 Chile Details
Novartis Investigative Site Withdrawn Vina del Mar Valparaiso 2540364 Chile Details
Novartis Investigative Site Recruiting Brno - Bohunice 625 00 Czechia Details
Novartis Investigative Site Active, not recruiting Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Active, not recruiting Bordeaux 33076 France Details
Novartis Investigative Site Withdrawn Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Withdrawn Berlin 13353 Germany Details
Novartis Investigative Site Completed Dresden 01307 Germany Details
Novartis Investigative Site Withdrawn Hong Kong Hong Kong Details
Novartis Investigative Site Withdrawn Bologna BO 40138 Italy Details
Novartis Investigative Site Active, not recruiting Milano MI 20162 Italy Details
Novartis Investigative Site Active, not recruiting Roma RM 00161 Italy Details
Novartis Investigative Site Withdrawn Shinagawa ku Tokyo 141 8625 Japan Details
Novartis Investigative Site Active, not recruiting Uijeongbu si Gyeonggi Do 11759 Korea, Republic of Details
Novartis Investigative Site Completed Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Withdrawn Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Active, not recruiting Krakow 31 531 Poland Details
Novartis Investigative Site Active, not recruiting Warszawa 02 776 Poland Details
Novartis Investigative Site Active, not recruiting Wroclaw 50 367 Poland Details
Novartis Investigative Site Active, not recruiting Lisboa 1099 023 Portugal Details
Novartis Investigative Site Active, not recruiting Porto 4200-072 Portugal Details
Novartis Investigative Site Active, not recruiting Moscow 125167 Russian Federation Details
Novartis Investigative Site Active, not recruiting Moscow 125284 Russian Federation Details
Novartis Investigative Site Active, not recruiting Saint Petersburg 191024 Russian Federation Details
Novartis Investigative Site Active, not recruiting Saint Petersburg 197341 Russian Federation Details
Novartis Investigative Site Recruiting Sevilla Andalucia 41009 Spain Details
Novartis Investigative Site Withdrawn Las Palmas de Gran Canaria 35010 Spain Details
Novartis Investigative Site Recruiting Madrid 28034 Spain Details
Novartis Investigative Site Recruiting Valencia 46026 Spain Details
Novartis Investigative Site Active, not recruiting Changhua 50006 Taiwan Details
Novartis Investigative Site Recruiting Taipei 10002 Taiwan Details
Novartis Investigative Site Active, not recruiting Taoyuan 33305 Taiwan Details
Novartis Investigative Site Recruiting Wirral Merseyside CH63 4JY United Kingdom Details
Novartis Investigative Site Recruiting London W12 0HS United Kingdom Details
Novartis Investigative Site Active, not recruiting Oxford OX3 7LJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field